Suppr超能文献

相似文献

1
Controlling ion channel function with renewable recombinant antibodies.
J Physiol. 2022 May;600(9):2023-2036. doi: 10.1113/JP282403. Epub 2022 Mar 17.
2
Genetically encoded intrabodies as high-precision tools to visualize and manipulate neuronal function.
Semin Cell Dev Biol. 2022 Jun;126:117-124. doi: 10.1016/j.semcdb.2021.11.004. Epub 2021 Nov 12.
3
Intracellular antibodies (intrabodies) and their therapeutic potential.
Handb Exp Pharmacol. 2008(181):343-73. doi: 10.1007/978-3-540-73259-4_15.
4
Ion channel engineering: perspectives and strategies.
J Mol Biol. 2015 Jan 16;427(1):190-204. doi: 10.1016/j.jmb.2014.09.001. Epub 2014 Sep 7.
6
Ion channel engineering for modulation and de novo generation of electrical excitability.
Curr Opin Biotechnol. 2019 Aug;58:100-107. doi: 10.1016/j.copbio.2019.01.004. Epub 2019 Feb 16.
7
Controlling ion channel trafficking by targeted ubiquitination and deubiquitination.
Methods Enzymol. 2021;654:139-167. doi: 10.1016/bs.mie.2021.03.007. Epub 2021 Apr 7.
9
Immunopharmacology: utilizing antibodies as ion channel modulators.
Expert Rev Clin Pharmacol. 2010 May;3(3):281-9. doi: 10.1586/ecp.10.18.
10
Screening Strategies for the Discovery of Ion Channel Monoclonal Antibodies.
Curr Protoc Pharmacol. 2018 Sep;82(1):e44. doi: 10.1002/cpph.44. Epub 2018 Aug 31.

引用本文的文献

本文引用的文献

1
Light-guided intrabodies for on-demand target recognition in human cells.
Chem Sci. 2021 Apr 8;12(16):5787-5795. doi: 10.1039/d1sc01331a. eCollection 2021 Apr 28.
2
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels.
Br J Pharmacol. 2021 Oct;178 Suppl 1:S157-S245. doi: 10.1111/bph.15539.
3
2020 FDA drug approvals.
Nat Rev Drug Discov. 2021 Feb;20(2):85-90. doi: 10.1038/d41573-021-00002-0.
4
Targeted deubiquitination rescues distinct trafficking-deficient ion channelopathies.
Nat Methods. 2020 Dec;17(12):1245-1253. doi: 10.1038/s41592-020-00992-6. Epub 2020 Nov 9.
5
Recombinant Antibodies in Basic Neuroscience Research.
Curr Protoc Neurosci. 2020 Dec;94(1):e106. doi: 10.1002/cpns.106.
6
Optogenetic control of protein binding using light-switchable nanobodies.
Nat Commun. 2020 Aug 13;11(1):4044. doi: 10.1038/s41467-020-17836-8.
7
A Novel Anti-Kv10.1 Nanobody Fused to Single-Chain TRAIL Enhances Apoptosis Induction in Cancer Cells.
Front Pharmacol. 2020 May 14;11:686. doi: 10.3389/fphar.2020.00686. eCollection 2020.
8
Tunable light and drug induced depletion of target proteins.
Nat Commun. 2020 Jan 16;11(1):304. doi: 10.1038/s41467-019-14160-8.
9
Antibody Structure and Function: The Basis for Engineering Therapeutics.
Antibodies (Basel). 2019 Dec 3;8(4):55. doi: 10.3390/antib8040055.
10
Optogenetic activation of intracellular antibodies for direct modulation of endogenous proteins.
Nat Methods. 2019 Nov;16(11):1095-1100. doi: 10.1038/s41592-019-0592-7. Epub 2019 Oct 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验